Your browser doesn't support javascript.
loading
Value assessment of oncology drugs using a weighted criterion-based approach.
Ezeife, Doreen A; Dionne, Francois; Fares, Aline Fusco; Cusano, Ellen Laura Rose; Fazelzad, Rouhi; Ng, Wenzie; Husereau, Don; Ali, Farzad; Sit, Christina; Stein, Barry; Law, Jennifer H; Le, Lisa; Ellis, Peter Michael; Berry, Scott; Peacock, Stuart; Mitton, Craig; Earle, Craig C; Chan, Kelvin K W; Leighl, Natasha B.
Afiliação
  • Ezeife DA; Department of Oncology, Tom Baker Cancer Centre, Calgary, Alberta, Canada.
  • Dionne F; Prioritize Consulting Ltd, Vancouver, British Columbia, Canada.
  • Fares AF; Department of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, Ontario, Canada.
  • Cusano ELR; Department of Oncology, Tom Baker Cancer Centre, Calgary, Alberta, Canada.
  • Fazelzad R; Department of Medical Oncology and Hematology, Library and Information Services, Princess Margaret Cancer Centre, Toronto, Ontario, Canada.
  • Ng W; Department of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, Ontario, Canada.
  • Husereau D; School of Epidemiology and Public Health, University of Ottawa, Ottawa, Ontario, Canada.
  • Ali F; Pfizer Inc, New York, New York.
  • Sit C; Lung Cancer Canada, Toronto, Ontario, Canada.
  • Stein B; Colorectal Cancer Canada, Montreal, Quebec, Canada.
  • Law JH; Department of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, Ontario, Canada.
  • Le L; Department of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, Ontario, Canada.
  • Ellis PM; Juravinski Cancer Centre, Hamilton, Ontario, Canada.
  • Berry S; Cancer Centre of Southeastern Ontario, Kingston, Ontario, Canada.
  • Peacock S; British Columbia Cancer Agency, Vancouver, British Columbia, Canada.
  • Mitton C; The University of British Columbia, Vancouver, British Columbia, Canada.
  • Earle CC; Sunnybrook Odette Cancer Centre, Toronto, Ontario, Canada.
  • Chan KKW; Sunnybrook Odette Cancer Centre, Toronto, Ontario, Canada.
  • Leighl NB; Department of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, Ontario, Canada.
Cancer ; 126(7): 1530-1540, 2020 04 01.
Article em En | MEDLINE | ID: mdl-31860138
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Análise Custo-Benefício / Oncologia / Antineoplásicos Tipo de estudo: Guideline / Prognostic_studies Limite: Humans País/Região como assunto: America do norte Idioma: En Revista: Cancer Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Canadá
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Análise Custo-Benefício / Oncologia / Antineoplásicos Tipo de estudo: Guideline / Prognostic_studies Limite: Humans País/Região como assunto: America do norte Idioma: En Revista: Cancer Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Canadá